NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
Back to search
Official data from USPTO
LARIO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LARIO THERAPEUTICS
ST13
US500000097503907Class
5, 42, 44
Filing
97503907
Registration
7637354
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
01/07/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
07/14/2022
Registration date
01/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2025
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Edinburgh, GB
Examiner
NOLASCO-ARIAS,KENNETH E
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Lario Therapeutics Ltd
Representatives
Deborah J Peckham Barclay Damon LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of neurological conditions; veterinary preparations for the treatment of neurological disorders; chemical preparations for medical and pharmaceutical purposesfor the treatment of neurological disorders; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of neuro-degenerative diseases; pharmaceutical preparations for the treatment of Parkinson's disease
Class 42
Researchdevelopmentevaluation and design services in the fields of medicalbiologicalbiotechnologicalgeneticlaboratory and pharmaceutical and veterinary preparations and medications; researchdevelopment and design of drugs and medicineveterinary preparationslaboratory and medical laboratory research and development services; researchdevelopmentevaluation and design services in relation to neurological disorders; researchdevelopmentevaluation and design services in relation to central nervous system disorders; researchdevelopmentevaluation and design services in relation to neuro-degenerative diseases; researchdevelopmentevaluation and design services in relation to Parkinson's Disease; exploitation of scientific research and technologyproviding information relating to scientific and technological research in the fields of drugspharmaceuticals and medicines in the nature of reports; development of prognostic and diagnostic tools; consultancy and information services relating to all of the aforesaid
Class 44
Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services
Publications
History of USPTO decisions and trademark events.
39 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/13/2024
RGIA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
12/02/2024
ERRS
TEAS REQUEST FOR REINSTATEMENT
12/02/2024
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
12/02/2024
ABN6
ABANDONMENT - NO USE STATEMENT FILED
12/02/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/29/2024
EX1G
SOU EXTENSION 1 GRANTED
10/29/2024
EXT1
SOU EXTENSION 1 FILED
10/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/29/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/23/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/23/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2024
PUBO
PUBLISHED FOR OPPOSITION
03/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2024
ALIE
ASSIGNED TO LIE
01/11/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/18/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/11/2023
GNSL
LETTER OF SUSPENSION E-MAILED
08/11/2023
CNSL
SUSPENSION LETTER WRITTEN
08/11/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/20/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/30/2023
GNRT
NON-FINAL ACTION E-MAILED
05/30/2023
CNRT
NON-FINAL ACTION WRITTEN
05/30/2023
DOCK
ASSIGNED TO EXAMINER
04/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2022
NWAP
NEW APPLICATION ENTERED
07/18/2022
Continuous trademark protection
Get notified about every new filing that threatens LARIO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.